Mechanisms of chloroquine resistance in malarial chemotherapy

Research output: Contribution to journalReview articlepeer-review

16 Citations (Scopus)

Abstract

Malaria is a protozoan parasitic infection threatening millions of people throughout the world. Over 6 million cases of malaria are treated annually and in Africa alone one million infant deaths can be attributed directly to malaria. Chloroquine has been the mainstay of malaria chemotherapy for nearly 50 years, but widespread resistance now limits its usefulness. Stephen Ward outlines the pharmacology of this drug. possible mechanisms of parasite resistance and pharmacologically based strategies that may be useful in attempting to override this resistance.
Original languageEnglish
Pages (from-to)241-246
Number of pages6
JournalTrends in Pharmacological Sciences
Volume9
Issue number7
DOIs
Publication statusPublished - 1 Jul 1988

Fingerprint

Dive into the research topics of 'Mechanisms of chloroquine resistance in malarial chemotherapy'. Together they form a unique fingerprint.

Cite this